Download Library

 
Download Library
Document Type
View Form 8937 - January 7, 2015
Form 8937
View Form 8937 - July 15, 2014
Form 8937
Theravance, Inc. Addendum to Conflict of Interest Policy with Regard to Theravance Biopharma, Inc. Matters
Corporate Governance
Audit Committee Charter
Corporate Governance
Comprehensive Compliance Program
Corporate Governance
Science and Technology Advisory Committee Charter.
Corporate Governance
Bylaws
Corporate Governance
Compensation Committee Charter
Corporate Governance
Nominating/Corporate Governance Committee Charter
Corporate Governance
FirstPrevious
2
= add file to Briefcase

Innoviva NASDAQ: INVA

$13.45 0.02 (0.15%) 12/13/17 1:50 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.